Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance data-Reference-Cited by-同舟云学术

Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance data

Published:2023-04-15 Issue: Volume: Page:e2023045
ISSN:2092-7193
Container-title:Epidemiology and Health
language:en
Short-container-title:Epidemiol Health

Author:

Min Hong Ki,Kim Hyeongsu,Jeong Ho Jin,Kim Se Hee,Kim Hae-Rim,Lee Sang-Heon,Lee KunSei,Shin Soon-Ae,Park Jong Heon

Publisher

Korean Society of Epidemiology

Subject

General Medicine

Reference38 articles.

1. Rheumatoid arthritis

2. Causes of Death in Rheumatoid Arthritis: How Do They Compare to the General Population?

3. Comorbidities in Patients with Rheumatoid Arthritis and Their Association with Patient-reported Outcomes: Results of Claims Data Linked to Questionnaire Survey

4. Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK inhibitor selectivity: new opportunities, better drugs?;Nature Reviews Rheumatology;2024-09-09

2. Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review;Dermatology and Therapy;2024-05-19

3. Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis – why cardiovascular risk factors do not equate to overt risk;Rheumatology;2024-01-18

4. Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden;RMD Open;2023-12

5. Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis;RMD Open;2023-11